In patients with small subcortical strokes, there is no benefit to be had from combination therapy using clopidogrel plus aspirin, interim results from the SPS3 (Secondary prevention of small subcortical strokes) study, presented by Oscar Benavente, University of British Columbia, Vancouver, Canada, at the the American Stroke Association’s International Stroke Conference 2012, revealed.
Oscar Benavente speaks on the results of the SPS3 study
Courtesy of the American Heart Association